Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a specially compounded medication designed to treat a wide range of skin conditions. This unique formulation combines the anti-inflammatory properties of hydrocortisone acetate with the antibacterial benefits of neomycin. It is particularly effective in treating skin conditions such as eczema, psoriasis, dermatitis, and other inflammatory skin conditions. Additionally, it can be used to treat bacterial skin infections, including impetigo and folliculitis.

This topical cream is dispensed in a pump mechanism, which allows for convenient and controlled application directly onto the skin. This ensures that the active ingredients are localized to the area of treatment, maximizing their effectiveness while minimizing potential side effects. It is crucial to follow the directions provided by your healthcare provider when using this medication to ensure optimal results.

While generally well-tolerated, some users may experience side effects such as skin irritation, burning, or itching. If you experience any of these symptoms, or any other adverse reactions, it is important to contact your healthcare provider immediately. They can provide guidance and, if necessary, adjust your treatment plan.

Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a potent and effective treatment for a variety of skin conditions. As with any medication, it is important to use it as directed by your healthcare provider. If you have any questions or concerns about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your healthcare needs.

This compounded formulation of Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. It is primarily used for the treatment of mild to moderate inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Additionally, it is effective in treating bacterial skin infections caused by susceptible organisms.

Patients are advised to use this formulation as directed by their healthcare provider and to avoid contact with the eyes. In case of accidental contact, the eyes should be thoroughly flushed with water. It is also recommended to avoid using this formulation on the face, groin, or axillae, and to use it for the shortest duration necessary to achieve the desired therapeutic effect.

Regular monitoring for signs of systemic absorption is crucial. This includes looking out for symptoms of adrenal suppression, Cushing's syndrome, and hyperglycemia. Patients should also be vigilant for signs of local irritation, such as burning, itching, dryness, and redness.

Prescribers should be aware of potential interactions of this formulation with other topical medications, including antifungals, antibiotics, and other corticosteroids. Additionally, this formulation may interact with systemic medications, including anticoagulants, diuretics, and oral contraceptives. Therefore, a thorough review of the patient's current medication regimen is necessary before prescribing this formulation.

If you have any questions or concerns about this formulation or its potential interactions, please do not hesitate to reach out for further information.

Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a compounded formulation designed to treat a variety of skin conditions. This medication combines the anti-inflammatory properties of hydrocortisone acetate, a corticosteroid, with the antibacterial action of neomycin, an antibiotic. The hydrocortisone acetate works to alleviate inflammation and irritation on the skin, while the neomycin targets and eliminates bacteria that can lead to infection.

This combination medication is effective in treating a range of skin conditions, including but not limited to eczema, psoriasis, dermatitis, and other inflammatory skin conditions. It is dispensed in a semisolid preparation via a pump mechanism, which allows for convenient and controlled application on the skin for localized treatment or absorption of the active ingredients.

When using Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream, it is crucial to adhere to the instructions provided by your healthcare provider. The cream should be applied to the affected skin area as directed. Prior to application, ensure your hands are clean to prevent further infection. Avoid applying the cream on broken or irritated skin. Unless instructed by your healthcare provider, do not cover the treated area with a bandage or any other covering.

For optimal results, it is important to use Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream for the full course of treatment as prescribed by your healthcare provider. Discontinuing the medication before the end of the prescribed course, even if symptoms improve, may not fully treat the condition and could lead to its recurrence. If you have any questions or concerns about the use of this medication, consult your healthcare provider for guidance.

Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a compounded formulation designed for the treatment of various skin conditions. This semisolid preparation is dispensed in a pump mechanism, allowing for convenient and controlled application on the skin. It is primarily used for localized treatment or absorption of active ingredients.

This formulation is indicated for the treatment of minor skin irritations, itching, and rashes caused by insect bites, poison ivy, poison oak, and poison sumac. It may also be used for other skin conditions as determined by your healthcare provider. The active ingredients in this formulation work to reduce inflammation and itching associated with certain skin conditions such as allergic reactions, eczema, and psoriasis.

It is important to use this formulation as directed by your healthcare provider. It should not be used for longer than two weeks unless otherwise instructed. If you have any questions or concerns about the use of this formulation, it is recommended to consult with your healthcare provider for further guidance.